Ishida Kyohei, Hasegawa Go, Hashimoto Takehisa, Ikeda Yohei, Hara Noboru, Nishiyama Tsutomu
Department of Urology, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, Minamiuonuma, Niigata, Japan.
Department of Pathology, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, Minamiuonuma, Niigata, Japan.
Case Rep Urol. 2024 Jan 17;2024:5586448. doi: 10.1155/2024/5586448. eCollection 2024.
A 64-year-old man was diagnosed with invasive bladder and right lower ureteral urothelial cancer with right pelvic lymph node and lung metastases. He received four courses of gemcitabine and cisplatin therapy. He underwent lung metastasectomy and radical cystoprostatectomy, with not only primary lesions but also metastatic lesions showing a complete response. New multiple lung metastases were revealed five months after adjuvant chemotherapy. On starting pembrolizumab therapy, the metastatic lesions are notably reduced in size. He is currently receiving pembrolizumab therapy, and no recurrence has been observed for over one year.
一名64岁男性被诊断为浸润性膀胱及右下输尿管尿路上皮癌,伴有右盆腔淋巴结及肺转移。他接受了四个疗程的吉西他滨和顺铂治疗。他接受了肺转移灶切除术及根治性膀胱前列腺切除术,不仅原发灶而且转移灶均显示完全缓解。辅助化疗五个月后发现新的多发肺转移。开始使用帕博利珠单抗治疗后,转移灶大小显著缩小。他目前正在接受帕博利珠单抗治疗,一年多来未观察到复发。